Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2025-12-27 @ 9:48 AM
Study NCT ID:
NCT00159861
Status:
COMPLETED
Last Update Posted:
2021-02-01
First Post:
2005-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-08
First Submit QC Date:
None
Study First Post Date:
2005-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-04-02
Results First Submit QC Date:
None
Results First Post Date:
2011-01-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-28
Last Update Post Date:
2021-02-01
Last Update Post Date Type:
ACTUAL